These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3769714)

  • 1. Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study.
    Krolewski AS; Warram JH; Rand LI; Christlieb AR; Busick EJ; Kahn CR
    Diabetes Care; 1986; 9(5):443-52. PubMed ID: 3769714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of proliferative diabetic retinopathy.
    Klein R; Klein BE; Moss SE
    Diabetes Care; 1992 Dec; 15(12):1875-91. PubMed ID: 1464243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy.
    Kofoed-Enevoldsen A; Jensen T; Borch-Johnsen K; Deckert T
    J Diabet Complications; 1987; 1(3):96-9. PubMed ID: 2969913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing natural history of nephropathy in type I diabetes.
    Krolewski AS; Warram JH; Christlieb AR; Busick EJ; Kahn CR
    Am J Med; 1985 May; 78(5):785-94. PubMed ID: 3993659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and progression of diabetic retinopathy in type I diabetic patients: a cohort study.
    Kalter-Leibovici O; Leibovici L; Loya N; Kremer I; Axer-Siegel R; Karp M; Laron Z
    Diabet Med; 1997 Oct; 14(10):858-66. PubMed ID: 9371479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study.
    Goldstein DE; Blinder KJ; Ide CH; Wilson RJ; Wiedmeyer HM; Little RR; England JD; Eddy M; Hewett JE; Anderson SK
    Ophthalmology; 1993 Aug; 100(8):1125-31; discussion 1131-2. PubMed ID: 8341491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ; Forrest KY; Ellis D; Becker DJ
    Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy.
    Krolewski AS; Barzilay J; Warram JH; Martin BC; Pfeifer M; Rand LI
    Diabetes; 1992 Apr; 41(4):430-7. PubMed ID: 1607070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of microangiopathy in children with type 1 diabetes mellitus: a 19-year retrospective study.
    Bouhanick B; Raguin H; Rohmer V; Ebran JM; Simard G; Limal JM
    Diabetes Metab; 2003 Sep; 29(4 Pt 1):395-402. PubMed ID: 14526267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cigarette smoking with diabetic retinopathy.
    Moss SE; Klein R; Klein BE
    Diabetes Care; 1991 Feb; 14(2):119-26. PubMed ID: 2060413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Age at Diagnosis and Time-Dependent Risk Factors on the Development of Diabetic Retinopathy in Patients with Type 1 Diabetes.
    Forga L; Goñi MJ; Ibáñez B; Cambra K; García-Mouriz M; Iriarte A
    J Diabetes Res; 2016; 2016():9898309. PubMed ID: 27213158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated blood pressure predicts the development of persistent proteinuria in the presence of poor glycemic control, in patients with type I diabetes.
    Derby L; Warram JH; Laffel LM; Krolewski AS
    Diabete Metab; 1989; 15(5 Pt 2):320-6. PubMed ID: 2612716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term study of mortality and vascular complications in juvenile-onset (type I) diabetes.
    Lestradet H; Papoz L; Hellouin de Menibus C; Levavasseur F; Besse J; Billaud L; Battistelli F; Tric P; Lestradet F
    Diabetes; 1981 Mar; 30(3):175-9. PubMed ID: 7202860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with the development of retinopathy 10 yr after the diagnosis of juvenile-onset type 1 diabetes in Taiwan: a cohort study from the CGJDES.
    Wang NK; Lai CC; Wang JP; Wu WC; Liu L; Yeh LK; Tseng HJ; Chang CJ; Lo FS;
    Pediatr Diabetes; 2016 Sep; 17(6):407-16. PubMed ID: 26332951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians.
    Nelson RG; Wolfe JA; Horton MB; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes; 1989 Apr; 38(4):435-40. PubMed ID: 2925007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for progression of background retinopathy in long-standing IDDM.
    Janka HU; Warram JH; Rand LI; Krolewski AS
    Diabetes; 1989 Apr; 38(4):460-4. PubMed ID: 2647552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of delayed motor nerve conduction and retinopathy in juvenile-onset diabetes mellitus.
    Hoffman WH; Hart ZH; Frank RN
    J Pediatr; 1983 Mar; 102(3):351-6. PubMed ID: 6827405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications?
    Benitez-Aguirre P; Craig ME; Cass HG; Sugden CJ; Jenkins AJ; Wang JJ; Cusumano J; Hodgson LA; Lee K; Wong TY; Donaghue KC
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):571-7. PubMed ID: 25477322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.